Lung Cancers News
Molecular testing may be underused in patients with metastatic NSCLC and may delay the start of systemic therapy, a study suggests.
Adding ipilimumab to nivolumab and chemotherapy improves responses in patients with operable non-small cell lung cancer, a phase 2 trial suggests.
Military pilots and the ground crews who fuel and maintain their aircraft have higher rates of certain cancers, a new study shows.
Patients receiving higher doses of hormone therapy and those receiving hormone therapy for at least 5 years may have a lower risk of lung cancer.
Among African-American cancer survivors, experiencing discrimination is associated with frailty, a study suggests.
Adding immunotherapy to chemotherapy may increase the risk of toxicity and likelihood of treatment discontinuation in patients with SCLC, a meta-analysis suggests.
The risk of hyperprogression is lower when atezolizumab is given upfront to patients with advanced non-small cell lung cancer, a study suggests.
A phase 2 trial suggests that frontline osimertinib and platinum-based chemotherapy is safe and effective in EGFR-mutated, advanced NSCLC.
A new study suggests that fluoroquinolones — but not other antibiotics — may reduce the efficacy of certain ICIs in certain cancers.
COVID-19 vaccination may reduce the risk of COVID-19 sequelae in patients with cancer, according to researchers.
Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.
A novel method of treating immune checkpoint inhibitor-associated myocarditis may decrease the risk of death from myotoxicity.
Cancer patients living in nursing homes are more likely to receive aggressive end-of-life care and die in the hospital, a study suggests.
Five-year data support the use of pembrolizumab plus pemetrexed-platinum chemotherapy as standard care for previously untreated, metastatic, EGFR/ALK-wild-type NSCLC, according to researchers.
Patients with cancer experienced symptoms of PTSD during the first year of the COVID-19 pandemic, a French study suggests.
Many cancer patients may be treated with drugs that were granted accelerated approval but do not provide a clinical benefit, a study suggests.
SBRT should be offered as an alternative to surgical resection for patients with early-stage LNET, according to researchers.
Critically ill patients with cancer who develop delirium have a higher risk of dying in the hospital or intensive care unit, a study suggests.
Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked.
The global incidence of mesothelioma has decreased in recent years, especially in highly developed countries, researchers found.